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When a transcription factor ismodified by small ubiquitin-likemodifier (SUMO), this usually represses its tran-
scriptional activity. In this issue of Developmental Cell, Lee et al. (2011) use a knockin mouse model to show
that SUMO-less SF-1 binds and activates inappropriate targets, causing changes in cell fates and endocrine
abnormalities.Small ubiquitin-like modifier (SUMO) is a
posttranslational protein modifier that is
attached to a large number of substrates
through the enzymatic activities of SUMO-
activating, -conjugating, and -ligating
enzymes (Yeh, 2009; Wang and Dasso,
2009).
SUMOylation (SUMO-modification) has
been shown to be involved in many
cellular processes, including transcrip-
tional regulation, cell cycle progression,
signal transduction, and DNA damage
repair. SUMOylation is finely balanced
by deSUMOylation, which is regulated
by a family of Sentrin/SUMO-specific
proteases (SENPs) (Yeh et al., 2000).
Both SUMOylation and deSUMOylation
are required for viable embryonic devel-
opment because deletion of the SUMO-
conjugating or deconjugating genes re-
sulted in embryonal lethality (Nacerddine
et al., 2005; Cheng, et al., 2007; Kang
et al., 2010).
SUMOylation can alter a protein’s
cellular localization, its biological activity,
and itsability to interactwithotherproteins.
Many transcription factors are SUMO
substrates. In general, SUMOylation of a
transcription factor usually results in a
depressed transcription activity due to
decrease in binding to the promoter region
(Gill, 2005; Hong et al., 2001). However, an
increasing number of examples have
shown that SUMOylation also plays a role
in transcriptional activation (Lyst and
Stancheva, 2007). Most of the published
SUMO studies on transcription factors
were based on overexpression in cell lines
or animals. Thus, the true physiologic
significance of SUMOylation of a specific
transcription factor remains unknown.Lee et al. used knockin mice to introduce
SUMO-less SF-1 throughout develop-
ment. They showed that SUMO-less SF-1
is stable and is localized in the same
cellular compartment as the wild-type
SF-1. However, they failed to observe an
enhanced transactivation at known target
genes. Instead, they observed an inappro-
priate activation of the sonic hedgehog
gene and of the hedgehog signaling
pathway; expression of SUMO-sensitive
genes in inappropriate cells resulted in
marked endocrine abnormality. These
results imply that the biological role of
SUMOylation on a specific transcription
factor is not all or none (i.e., activation
versus suppression), but is indeed much
more complex. One can argue that
substituting arginine for lysine could intro-
duce subtle conformational changes in
SF-1 that resulted in binding to ectopic
promoters. On the other hand, the current
study could also imply that SF-1 needs to
be maintained in a SUMOylated state
during development of testes so that inap-
propriate activation of the sonic hedgehog
pathway would not occur.
SUMOylation or deSUMOylation can
regulate transcription in a number of
ways.First,SUMOylationofa transcription
factor could affect its ability to bind to
a specific promoter region. This can be
seen in the case of heat-shock protein
transcription factor 1 (HSF1), in which
SUMOylated HSF1 enhances its DNA
binding capability, resulting in the regula-
tion of genes involved in heat-shock re-
sponse (Hong et al., 2001). Conversely,
a SENP could deconjugate SUMOylated
HSF1 to reduce its DNA binding activity.
Second, SUMOylation of a transcriptionDevelopmental Cell 21factor could enhance its interaction with
proteins that contain a SUMO-interacting
motif (SIM), leading to recruitment of
coactivators or repressors. This SUMO/
SIM interaction can be abolished by the
presence of SENPs. Third, enzymatic
activity of transcription machinery or
chromatin regulators might be regulated
by SUMOylation or deSUMOylation.
Fourth, a transcription factor complex
can be regulated by SUMOylation or
deSUMOylation. For example, SENP1
removes SUMO from HIF1a (hypoxia-
inducible factor 1a) to enhance its
binding to HIF1b to increase its tran-
scriptional activity (Cheng et al., 2007).
Fifth, a transcription repressor complex
can be regulated by SUMOylation or
deSUMOylation. For example, Pc2 of
the polycomb repressor complex is
SUMOylated,which is required for binding
to H3K27me3 to mediate transcriptional
repression. SENP2 can specifically regu-
late SUMOylated Pc2 to activate re-
pressed genes during development
(Kang et al., 2010). Sixth, SUMOylation
or deSUMOylation can regulate stability
of a transcription factor. For example,
SUMOylatedHIF1acanbind toaVHL-con-
taining ubiquitin E3 ligase to be degraded
in the hypoxic environment (Cheng, et al.,
2007). SENP1 deconjugates SUMOylated
HIF1a to prevent its binding to its E3 ligase,
thus stabilizing HIF1a.
Returning to the report by Lee et al., it is
easy to see why SUMO-less SF-1 would
alter development of endocrine organs
through ectopic activation of inappro-
priate genes. During development, it is
likely that SF-1 undergoes cycles of
SUMOylation and deSUMOylation in a, August 16, 2011 ª2011 Elsevier Inc. 191
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Previewscell-type-specific manner. Removing the
lysine residues required for SUMOylation
would remove a dynamic component of
developmental regulation. For example,
Pc2 is SUMOylated in early development
to suppress transcription of genes re-
quired for later development, such as
Hox, Gata4, and Gata6 (Kang, et al.,
2010). However, at E9.5, there is an
increase in SENP2 expression, leading
to deSUMOylation of Pc2 and lifting of
transcription suppression from the poly-
comb complex. Although not pertinent to
the current manuscript, lysine residues
can also be ubiquitinated, Neddylated,
or acetylated; these posttranslational192 Developmental Cell 21, August 16, 2011modifications may also play important
roles in the life cycle of a transcriptional
factor during development.
REFERENCES
Cheng, J., Kang, X., Zhang, S., and Yeh, E.T.H.
(2007). Cell 131, 584–595.
Gill, G. (2005). Curr. Opin. Genet. Dev. 15,
536–541.
Hong, Y., Rogers, R., Matunis, M.J., Mayhew,
C.N., Goodson, M.L., Park-Sarge, O.K., and
Sarge, K.D. (2001). J. Biol. Chem. 276, 40263–
40267.
Kang, X., Qi, Y., Zuo, Y., Wang, Q., Zou, Y.,
Schwartz, R.J., Cheng, J., and Yeh, E.T.H. (2010).
Mol. Cell 38, 191–201.ª2011 Elsevier Inc.Lee, F.Y., Faivre, E.J., Suzawa, M., Lontok, E.,
Ebert, D., Cai, F., Belsham, D.D., and Ingraham,
H.A. (2011). Dev. Cell 21, this issue, 315–327.
Lyst, M.J., and Stancheva, I. (2007). Biochem. Soc.
Trans. 35, 1389–1392.
Nacerddine, K., Lehembre, F., Bhaumik, M., Artus,
J., Cohen-Tannoudji, M., Babinet, C., Pandolfi,
P.P., and Dejean, A. (2005). Dev. Cell 9, 769–779.
Wang, Y., and Dasso, M. (2009). J. Cell Sci. 122,
4249–4252.
Yeh, E.T.H. (2009). J. Biol. Chem. 284, 8223–8227.
Yeh, E.T.H., Gong, L., and Kamitani, T. (2000).
Gene 248, 1–14.
